Regulatory review processes are evolving, and AI is playing a growing role in enhancing efficiency and compliance. MLR Bot, launching in late 2025, is the industry’s AI agent for medical, legal, and regulatory (MLR) review, designed to streamline content validation, reduce errors, and accelerate approvals.

Be among the first to explore the potential of AI in MLR review in PromoMats. Sign up now to receive updates and early access opportunities. 


"The area where GenAI has the most potential is MLR and it's exciting to see Veeva embrace that with MLR Bot." 

Dr. Samin Saeed, Vice President, Early Assets Medical, GSK
Learn more

"Veeva's latest advances will boost field productivity, increase compliance, and speed up MLR review, enabling easier AI adoption in life sciences."

Raimond Jähn, Vice President Information Technology, BioNTech SE 
Learn more

MLR Bot's key capabilities include:


  • Editorial Check
    Identifies spelling, grammar, and restricted terminology issues
  • Brand Guidelines
    Ensure proper trademark, copyright, and privacy statement compliance 
  • Market Guidelines
    Automate black box warnings, ISI/PI inclusion, and adherence to regulatory updates
  • Channel Rules
    Confirms platform-specific requirements, including QR codes, accessibility, and opt-out options
  • MLR Assistant
    Provides industry-specific responses to questions about the quality and accuracy of the content